Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB26FR1QK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,287
Award facts
- Contract value 100% obligated
- $35,286.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) prefilled pens with a ceiling value of $35,286.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on October 30, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Ozempic is a widely used diabetes medication, and this procurement supports the Defense Health Agency's pharmaceutical supply requirements for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities globally to support military healthcare programs. AmerisourceBergen's extensive federal contract portfolio with the DLA demonstrates its established capability to meet federal medical procurement requirements for both brand-name and generic pharmaceuticals across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FR1QK?
SPE2DB26FR1QK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FR1QK worth?
The government has obligated $35,287 on SPE2DB26FR1QK.
Is contract SPE2DB26FR1QK an order under another contract?
Yes. SPE2DB26FR1QK is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB26FR1QK competed?
The extent of competition for SPE2DB26FR1QK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award